Global and United States Alzheimer's Disease Drug Market Report & Forecast 2022-2028

• Description
• Table of Contents
• Table of Figures
• PDF Download

• Description
• Table of Contents
• Table of Figures
• PDF Download

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

Market Analysis and Insights: Global and United States Alzheimer's Disease Drug Market
This report focuses on global and United States Alzheimer's Disease Drug market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Alzheimer's Disease Drug market size is estimated to be worth US$ 3676.9 million in 2022 and is forecast to a readjusted size of US$ 4020.5 million by 2028 with a CAGR of 1.5% during the review period. Fully considering the economic change by this health crisis, by Type, Donepezil accounting for % of the Alzheimer's Disease Drug global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Early to Moderate Stages was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

Global Alzheimer's Disease Drug Scope and Market Size
Alzheimer's Disease Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Alzheimer's Disease Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Alzheimer's Disease Drug market is segmented into
    Donepezil
    Memantine
    Rivastigmine
    Others

Segment by Application, the Alzheimer's Disease Drug market is segmented into
    Early to Moderate Stages
    Moderate to Severe Stages

Regional and Country-level Analysis
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Alzheimer's Disease Drug Market Share Analysis
Alzheimer's Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Alzheimer's Disease Drug business, the date to enter into the Alzheimer's Disease Drug market, Alzheimer's Disease Drug product introduction, recent developments, etc.

The major vendors covered:
    Allergan
    Eisai
    Novartis
    Daiichi Sankyo
    Merz Pharma
    Pfizer
    Johnson & Johnson
    Lundbeck

 1 Study Coverage
    1.1 Alzheimer's Disease Drug Product Introduction
    1.2 Global Alzheimer's Disease Drug Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Alzheimer's Disease Drug Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Alzheimer's Disease Drug Sales in Volume for the Year 2017-2028
    1.3 United States Alzheimer's Disease Drug Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Alzheimer's Disease Drug Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Alzheimer's Disease Drug Sales in Volume for the Year 2017-2028
    1.4 Alzheimer's Disease Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Alzheimer's Disease Drug in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Alzheimer's Disease Drug Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Alzheimer's Disease Drug Market Dynamics
        1.5.1 Alzheimer's Disease Drug Industry Trends
        1.5.2 Alzheimer's Disease Drug Market Drivers
        1.5.3 Alzheimer's Disease Drug Market Challenges
        1.5.4 Alzheimer's Disease Drug Market Restraints
    1.6 Study Objectives
    1.7 Years Considered

 2 Market by Type
    2.1 Alzheimer's Disease Drug Market Segment by Type
        2.1.1 Donepezil
        2.1.2 Memantine
        2.1.3 Rivastigmine
        2.1.4 Others
    2.2 Global Alzheimer's Disease Drug Market Size by Type
        2.2.1 Global Alzheimer's Disease Drug Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Alzheimer's Disease Drug Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Alzheimer's Disease Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Alzheimer's Disease Drug Market Size by Type
        2.3.1 United States Alzheimer's Disease Drug Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Alzheimer's Disease Drug Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Alzheimer's Disease Drug Average Selling Price (ASP) by Type (2017, 2022 & 2028)

 3 Market by Application
    3.1 Alzheimer's Disease Drug Market Segment by Application
        3.1.1 Early to Moderate Stages
        3.1.2 Moderate to Severe Stages
    3.2 Global Alzheimer's Disease Drug Market Size by Application
        3.2.1 Global Alzheimer's Disease Drug Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Alzheimer's Disease Drug Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Alzheimer's Disease Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Alzheimer's Disease Drug Market Size by Application
        3.3.1 United States Alzheimer's Disease Drug Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Alzheimer's Disease Drug Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Alzheimer's Disease Drug Average Selling Price (ASP) by Application (2017, 2022 & 2028)

 4 Global Alzheimer's Disease Drug Competitor Landscape by Company
    4.1 Global Alzheimer's Disease Drug Market Size by Company
        4.1.1 Top Global Alzheimer's Disease Drug Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Alzheimer's Disease Drug Revenue by Manufacturer (2017-2022)
        4.1.3 Global Alzheimer's Disease Drug Sales by Manufacturer (2017-2022)
        4.1.4 Global Alzheimer's Disease Drug Price by Manufacturer (2017-2022)
    4.2 Global Alzheimer's Disease Drug Concentration Ratio (CR)
        4.2.1 Alzheimer's Disease Drug Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Alzheimer's Disease Drug in 2021
        4.2.3 Global Alzheimer's Disease Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Alzheimer's Disease Drug Manufacturing Base Distribution, Product Type
        4.3.1 Global Alzheimer's Disease Drug Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Alzheimer's Disease Drug Product Type
        4.3.3 Date of International Manufacturers Enter into Alzheimer's Disease Drug Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Alzheimer's Disease Drug Market Size by Company
        4.5.1 Top Alzheimer's Disease Drug Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Alzheimer's Disease Drug Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Alzheimer's Disease Drug Sales by Players (2020, 2021 & 2022)

 5 Global Alzheimer's Disease Drug Market Size by Region
    5.1 Global Alzheimer's Disease Drug Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Alzheimer's Disease Drug Market Size in Volume by Region (2017-2028)
        5.2.1 Global Alzheimer's Disease Drug Sales in Volume by Region: 2017-2022
        5.2.2 Global Alzheimer's Disease Drug Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Alzheimer's Disease Drug Market Size in Value by Region (2017-2028)
        5.3.1 Global Alzheimer's Disease Drug Sales in Value by Region: 2017-2022
        5.3.2 Global Alzheimer's Disease Drug Sales in Value by Region: 2023-2028

 6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Alzheimer's Disease Drug Market Size YoY Growth 2017-2028
        6.1.2 North America Alzheimer's Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Alzheimer's Disease Drug Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Alzheimer's Disease Drug Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 China Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
    6.3 Europe
        6.3.1 Europe Alzheimer's Disease Drug Market Size YoY Growth 2017-2028
        6.3.2 Europe Alzheimer's Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Alzheimer's Disease Drug Market Size YoY Growth 2017-2028
        6.4.2 Latin America Alzheimer's Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
        6.4.6 Colombia
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Alzheimer's Disease Drug Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Alzheimer's Disease Drug Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 UAE

 7 Company Profiles
    7.1 Allergan
        7.1.1 Allergan Corporation Information
        7.1.2 Allergan Description and Business Overview
        7.1.3 Allergan Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Allergan Alzheimer's Disease Drug Products Offered
        7.1.5 Allergan Recent Development
    7.2 Eisai
        7.2.1 Eisai Corporation Information
        7.2.2 Eisai Description and Business Overview
        7.2.3 Eisai Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Eisai Alzheimer's Disease Drug Products Offered
        7.2.5 Eisai Recent Development
    7.3 Novartis
        7.3.1 Novartis Corporation Information
        7.3.2 Novartis Description and Business Overview
        7.3.3 Novartis Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Novartis Alzheimer's Disease Drug Products Offered
        7.3.5 Novartis Recent Development
    7.4 Daiichi Sankyo
        7.4.1 Daiichi Sankyo Corporation Information
        7.4.2 Daiichi Sankyo Description and Business Overview
        7.4.3 Daiichi Sankyo Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Daiichi Sankyo Alzheimer's Disease Drug Products Offered
        7.4.5 Daiichi Sankyo Recent Development
    7.5 Merz Pharma
        7.5.1 Merz Pharma Corporation Information
        7.5.2 Merz Pharma Description and Business Overview
        7.5.3 Merz Pharma Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Merz Pharma Alzheimer's Disease Drug Products Offered
        7.5.5 Merz Pharma Recent Development
    7.6 Pfizer
        7.6.1 Pfizer Corporation Information
        7.6.2 Pfizer Description and Business Overview
        7.6.3 Pfizer Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Pfizer Alzheimer's Disease Drug Products Offered
        7.6.5 Pfizer Recent Development
    7.7 Johnson & Johnson
        7.7.1 Johnson & Johnson Corporation Information
        7.7.2 Johnson & Johnson Description and Business Overview
        7.7.3 Johnson & Johnson Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Johnson & Johnson Alzheimer's Disease Drug Products Offered
        7.7.5 Johnson & Johnson Recent Development
    7.8 Lundbeck
        7.8.1 Lundbeck Corporation Information
        7.8.2 Lundbeck Description and Business Overview
        7.8.3 Lundbeck Alzheimer's Disease Drug Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 Lundbeck Alzheimer's Disease Drug Products Offered
        7.8.5 Lundbeck Recent Development

 8 Industry Chain and Sales Channels Analysis
    8.1 Alzheimer's Disease Drug Industry Chain Analysis
    8.2 Alzheimer's Disease Drug Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Alzheimer's Disease Drug Distributors
    8.3 Alzheimer's Disease Drug Production Mode & Process
    8.4 Alzheimer's Disease Drug Sales and Marketing
        8.4.1 Alzheimer's Disease Drug Sales Channels
        8.4.2 Alzheimer's Disease Drug Distributors
    8.5 Alzheimer's Disease Drug Customers

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables
    Table 1. Alzheimer's Disease Drug CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Alzheimer's Disease Drug Market Trends
    Table 3. Alzheimer's Disease Drug Market Drivers
    Table 4. Alzheimer's Disease Drug Market Challenges
    Table 5. Alzheimer's Disease Drug Market Restraints
    Table 6. Global Alzheimer's Disease Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Alzheimer's Disease Drug Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Alzheimer's Disease Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Alzheimer's Disease Drug Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Alzheimer's Disease Drug Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Alzheimer's Disease Drug Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Alzheimer's Disease Drug Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Alzheimer's Disease Drug Sales by Manufacturer, (M Units), 2017-2022
    Table 14. Global Alzheimer's Disease Drug Sales Share by Manufacturer, 2017-2022
    Table 15. Global Alzheimer's Disease Drug Price by Manufacturer (2017-2022) & (US$/Unit)
    Table 16. Global Alzheimer's Disease Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Alzheimer's Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer's Disease Drug as of 2021)
    Table 18. Top Players of Alzheimer's Disease Drug in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Alzheimer's Disease Drug Product Type
    Table 20. Date of International Manufacturers Enter into Alzheimer's Disease Drug Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Alzheimer's Disease Drug Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Alzheimer's Disease Drug Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Alzheimer's Disease Drug Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Alzheimer's Disease Drug Sales by Players, (M Units), 2020, 2021 & 2022
    Table 26. United States Alzheimer's Disease Drug Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Alzheimer's Disease Drug Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Alzheimer's Disease Drug Sales in Volume by Region (2017-2022) & (M Units)
    Table 29. Global Alzheimer's Disease Drug Sales in Volume Forecast by Region (2023-2028) & (M Units)
    Table 30. Global Alzheimer's Disease Drug Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Alzheimer's Disease Drug Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Alzheimer's Disease Drug Sales in Volume by Country (2017-2028) & (M Units)
    Table 33. North America Alzheimer's Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Alzheimer's Disease Drug Sales in Volume by Region (2017-2028) & (M Units)
    Table 35. Asia Pacific Alzheimer's Disease Drug Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Alzheimer's Disease Drug Sales in Volume by Country (2017-2028) & (M Units)
    Table 37. Europe Alzheimer's Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Alzheimer's Disease Drug Sales in Volume by Country (2017-2028) & (M Units)
    Table 39. Latin Americaa Alzheimer's Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Alzheimer's Disease Drug Sales in Volume by Country (2017-2028) & (M Units)
    Table 41. Middle East and Africa Alzheimer's Disease Drug Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Allergan Corporation Information
    Table 43. Allergan Description and Business Overview
    Table 44. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 45. Allergan Alzheimer's Disease Drug Product
    Table 46. Allergan Recent Development
    Table 47. Eisai Corporation Information
    Table 48. Eisai Description and Business Overview
    Table 49. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 50. Eisai Product
    Table 51. Eisai Recent Development
    Table 52. Novartis Corporation Information
    Table 53. Novartis Description and Business Overview
    Table 54. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 55. Novartis Product
    Table 56. Novartis Recent Development
    Table 57. Daiichi Sankyo Corporation Information
    Table 58. Daiichi Sankyo Description and Business Overview
    Table 59. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 60. Daiichi Sankyo Product
    Table 61. Daiichi Sankyo Recent Development
    Table 62. Merz Pharma Corporation Information
    Table 63. Merz Pharma Description and Business Overview
    Table 64. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 65. Merz Pharma Product
    Table 66. Merz Pharma Recent Development
    Table 67. Pfizer Corporation Information
    Table 68. Pfizer Description and Business Overview
    Table 69. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 70. Pfizer Product
    Table 71. Pfizer Recent Development
    Table 72. Johnson & Johnson Corporation Information
    Table 73. Johnson & Johnson Description and Business Overview
    Table 74. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 75. Johnson & Johnson Product
    Table 76. Johnson & Johnson Recent Development
    Table 77. Lundbeck Corporation Information
    Table 78. Lundbeck Description and Business Overview
    Table 79. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 80. Lundbeck Product
    Table 81. Lundbeck Recent Development
    Table 82. Key Raw Materials Lists
    Table 83. Raw Materials Key Suppliers Lists
    Table 84. Alzheimer's Disease Drug Customers List
    Table 85. Alzheimer's Disease Drug Distributors List
    Table 86. Research Programs/Design for This Report
    Table 87. Key Data Information from Secondary Sources
    Table 88. Key Data Information from Primary Sources
List of Figures
    Figure 1. Alzheimer's Disease Drug Product Picture
    Figure 2. Global Alzheimer's Disease Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Alzheimer's Disease Drug Market Size 2017-2028 (US$ Million)
    Figure 4. Global Alzheimer's Disease Drug Sales 2017-2028 (M Units)
    Figure 5. United States Alzheimer's Disease Drug Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Alzheimer's Disease Drug Market Size 2017-2028 (US$ Million)
    Figure 7. United States Alzheimer's Disease Drug Sales 2017-2028 (M Units)
    Figure 8. United States Alzheimer's Disease Drug Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Alzheimer's Disease Drug Market Share in Global, in Volume (M Units) 2017-2028
    Figure 10. Alzheimer's Disease Drug Report Years Considered
    Figure 11. Product Picture of Donepezil
    Figure 12. Product Picture of Memantine
    Figure 13. Product Picture of Rivastigmine
    Figure 14. Product Picture of Others
    Figure 15. Global Alzheimer's Disease Drug Market Share by Type in 2022 & 2028
    Figure 16. Global Alzheimer's Disease Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 17. Global Alzheimer's Disease Drug Sales Market Share in Value by Type (2017-2028)
    Figure 18. Global Alzheimer's Disease Drug Sales by Type (2017-2028) & (M Units)
    Figure 19. Global Alzheimer's Disease Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 20. Global Alzheimer's Disease Drug Price by Type (2017-2028) & (US$/Unit)
    Figure 21. United States Alzheimer's Disease Drug Market Share by Type in 2022 & 2028
    Figure 22. United States Alzheimer's Disease Drug Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 23. United States Alzheimer's Disease Drug Sales Market Share in Value by Type (2017-2028)
    Figure 24. United States Alzheimer's Disease Drug Sales by Type (2017-2028) & (M Units)
    Figure 25. United States Alzheimer's Disease Drug Sales Market Share in Volume by Type (2017-2028)
    Figure 26. United States Alzheimer's Disease Drug Price by Type (2017-2028) & (US$/Unit)
    Figure 27. Product Picture of Early to Moderate Stages
    Figure 28. Product Picture of Moderate to Severe Stages
    Figure 29. Global Alzheimer's Disease Drug Market Share by Application in 2022 & 2028
    Figure 30. Global Alzheimer's Disease Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 31. Global Alzheimer's Disease Drug Sales Market Share in Value by Application (2017-2028)
    Figure 32. Global Alzheimer's Disease Drug Sales by Application (2017-2028) & (M Units)
    Figure 33. Global Alzheimer's Disease Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 34. Global Alzheimer's Disease Drug Price by Application (2017-2028) & (US$/Unit)
    Figure 35. United States Alzheimer's Disease Drug Market Share by Application in 2022 & 2028
    Figure 36. United States Alzheimer's Disease Drug Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 37. United States Alzheimer's Disease Drug Sales Market Share in Value by Application (2017-2028)
    Figure 38. United States Alzheimer's Disease Drug Sales by Application (2017-2028) & (M Units)
    Figure 39. United States Alzheimer's Disease Drug Sales Market Share in Volume by Application (2017-2028)
    Figure 40. United States Alzheimer's Disease Drug Price by Application (2017-2028) & (US$/Unit)
    Figure 41. North America Alzheimer's Disease Drug Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 42. North America Alzheimer's Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 43. U.S. Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Canada Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Europe Alzheimer's Disease Drug Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 46. Europe Alzheimer's Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 47. Germany Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 48. France Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. U.K. Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Italy Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Russia Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Asia-Pacific Alzheimer's Disease Drug Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 53. Asia-Pacific Alzheimer's Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 54. China Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Japan Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. South Korea Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. India Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 58. Australia Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 59. China Taiwan Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Indonesia Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. Thailand Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. Malaysia Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Latin America Alzheimer's Disease Drug Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 64. Latin America Alzheimer's Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 65. Mexico Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Brazil Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Argentina Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Colombia Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Middle East & Africa Alzheimer's Disease Drug Sales in Volume Growth Rate 2017-2028 (M Units)
    Figure 70. Middle East & Africa Alzheimer's Disease Drug Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Turkey Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Saudi Arabia Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. UAE Alzheimer's Disease Drug Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Alzheimer's Disease Drug Value Chain
    Figure 75. Alzheimer's Disease Drug Production Process
    Figure 76. Channels of Distribution
    Figure 77. Distributors Profiles
    Figure 78. Bottom-up and Top-down Approaches for This Report
    Figure 79. Data Triangulation
    Figure 80. Key Executives Interviewed

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

Market Analysis and Insights: Global and United States Alzheimer's Disease Drug Market
This report focuses on global and United States Alzheimer's Disease Drug market, also covers the segmentation data of other regions in regional level and county level.

Due to the COVID-19 pandemic, the global Alzheimer's Disease Drug market size is estimated to be worth US$ 3676.9 million in 2022 and is forecast to a readjusted size of US$ 4020.5 million by 2028 with a CAGR of 1.5% during the review period. Fully considering the economic change by this health crisis, by Type, Donepezil accounting for % of the Alzheimer's Disease Drug global market in 2021, is projected to value US$  million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Early to Moderate Stages was the leading segment, accounting for over  percent market share in 2021, and altered to an  % CAGR throughout this forecast period.

The major players in global Alzheimer’s Disease Drug market include Allergan, Eisai, Novartis, Daiichi Sankyo, Merz Pharma, Pfizer, Johnson & Johnson, Lundbeck, etc. The top 3 players hold over 60% of global shares. Europe and North America are main markets, they occupy over 70% of the global market. Memantine and Donepezil are the main types, with a share about 70%. Early to Moderate Stages is the key application, which covers over 55% shares.

Global Alzheimer's Disease Drug Scope and Market Size
Alzheimer's Disease Drug market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Alzheimer's Disease Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Alzheimer's Disease Drug market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type, the Alzheimer's Disease Drug market is segmented into
    Donepezil
    Memantine
    Rivastigmine
    Others

Segment by Application, the Alzheimer's Disease Drug market is segmented into
    Early to Moderate Stages
    Moderate to Severe Stages

Regional and Country-level Analysis
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        China Taiwan
        Indonesia
        Thailand
        Malaysia
    Latin America
        Mexico
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE

Competitive Landscape and Alzheimer's Disease Drug Market Share Analysis
Alzheimer's Disease Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Alzheimer's Disease Drug business, the date to enter into the Alzheimer's Disease Drug market, Alzheimer's Disease Drug product introduction, recent developments, etc.

The major vendors covered:
    Allergan
    Eisai
    Novartis
    Daiichi Sankyo
    Merz Pharma
    Pfizer
    Johnson & Johnson
    Lundbeck